ImmunityBio, Inc. — Director's Dealing 2018

Nov 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-11-21

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-21	Common Stock	S	22900	$2.0182	Disposed	298820	Indirect
2018-11-23	Common Stock	S	9312	$2.01	Disposed	289508	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 22,900 shares sold in the price range of $2.01 to $2.06 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.